 Guggenheim Capital LLC raised its position in Tekla Life Sciences Investors NYSE:HQL by 44.2 during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission SEC. The firm owned 24,055 shares of the companys stock after buying an additional 7,370 shares during the quarter. Guggenheim ... 